Trial Profile
Clinical Trials Insight: 700051689
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2009
Price :
$35
*
At a glance
- Drugs Amiloride/spironolactone (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Hemodynamic Therapeutics
- 08 Dec 2009 New trial record.
- 08 Dec 2009 Primary endpoint 'diastolic blood pressure' has been met.
- 08 Dec 2009 Primary endpoint 'systolic blood pressure' has been met.